BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2297197)

  • 1. Rhabdomyolysis and acute renal failure induced by combination lovastatin and gemfibrozil therapy.
    Marais GE; Larson KK
    Ann Intern Med; 1990 Feb; 112(3):228-30. PubMed ID: 2297197
    [No Abstract]   [Full Text] [Related]  

  • 2. Rhabdomyolysis associated with the combined use of hydroxymethylglutaryl-coenzyme A reductase inhibitors with gemfibrozil and macrolide antibiotics.
    Landesman KA; Stozek M; Freeman NJ
    Conn Med; 1999 Aug; 63(8):455-7. PubMed ID: 10500341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhabdomyolysis and renal failure secondary to combination therapy of hyperlipidemia with lovastatin and gemfibozil.
    Knoll RW; Ciafone R; Galen M
    Conn Med; 1993 Sep; 57(9):593-4. PubMed ID: 8252847
    [No Abstract]   [Full Text] [Related]  

  • 4. Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy.
    Pierce LR; Wysowski DK; Gross TP
    JAMA; 1990 Jul; 264(1):71-5. PubMed ID: 2355431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatitis and rhabdomyolysis associated with lovastatin-gemfibrozil therapy.
    Abdul-Ghaffar NU; el-Sonbaty MR
    J Clin Gastroenterol; 1995 Dec; 21(4):340-1. PubMed ID: 8583121
    [No Abstract]   [Full Text] [Related]  

  • 6. Rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy.
    Pogson GW; Kindred LH; Carper BG
    Am J Cardiol; 1999 Apr; 83(7):1146. PubMed ID: 10190540
    [No Abstract]   [Full Text] [Related]  

  • 7. [Rhabdomyolysis complicated with acute renal insufficiency in a patient treated with gemfibrozil and cerivastatin].
    Vascónez Espinosa F; Gómez Rodríguez N; Martín Joven A; Posada García FJ
    Rev Clin Esp; 2001 Apr; 201(4):228-9. PubMed ID: 11447919
    [No Abstract]   [Full Text] [Related]  

  • 8. A case with severe rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy--a case report.
    Ozdemir O; Boran M; Gökçe V; Uzun Y; Koçak B; Korkmaz S
    Angiology; 2000 Aug; 51(8):695-7. PubMed ID: 10959522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhabdomyolysis and acute renal failure after changing statin-fibrate combinations.
    Oldemeyer JB; Lund RJ; Koch M; Meares AJ; Dunlay R
    Cardiology; 2000; 94(2):127-8. PubMed ID: 11173785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhabdomyolysis due to combination therapy with cerivastatin and gemfibrozil.
    Alexandridis G; Pappas GA; Elisaf MS
    Am J Med; 2000 Aug; 109(3):261-2. PubMed ID: 11023440
    [No Abstract]   [Full Text] [Related]  

  • 11. Delayed presentation of severe rhabdomyolysis leading to acute kidney injury following atorvastatin-gemfibrozil combination therapy: a case report.
    Dalugama C; Pathirage M; Kularatne SAM
    J Med Case Rep; 2018 May; 12(1):143. PubMed ID: 29784023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhabdomyolysis and acute renal failure in a heart transplant recipient treated with hypolipemiants.
    de Alava E; Sola JJ; Lozano MD; Pardo-Mindán FJ
    Nephron; 1994; 66(2):242-3. PubMed ID: 8139752
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rhabdomyolysis, acute renal failure and use of cerivastatin combined with gemfibrozil. New evidence].
    SantaCruz PL; González A; León ME; Fernández MY
    Nefrologia; 2002; 22(3):301-2. PubMed ID: 12123135
    [No Abstract]   [Full Text] [Related]  

  • 14. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
    Chang JT; Staffa JA; Parks M; Green L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhabdomyolysis with HMG CoA reductase inhibitors: a class effect?
    Langford NJ; Kendall MJ
    J Clin Pharm Ther; 2001 Dec; 26(6):391-5. PubMed ID: 11722675
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe rhabdomyolysis associated with the cerivastin-gemfibrozil combination therapy: report of a case.
    Lau TK; Leachman DR; Lufschanowski R
    Tex Heart Inst J; 2001; 28(2):142-5. PubMed ID: 11453128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhabdomyolysis from the combination of a statin and gemfibrozil: an uncommon but serious adverse reaction.
    Kind AH; Zakowski LJ; McBride PE
    WMJ; 2002; 101(7):53-6. PubMed ID: 12426921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of a mouse model of rhabdomyolysis by coadministration of statin and fibrate.
    Watanabe K; Oda S; Matsubara A; Akai S; Yokoi T
    Toxicol Lett; 2019 Jun; 307():49-58. PubMed ID: 30853469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhabdomyolysis and acute renal failure associated with gemfibrozil therapy.
    Górriz JL; Sancho A; Lopez-Martin JM; Alcoy E; Catalán C; Pallardó LM
    Nephron; 1996; 74(2):437-8. PubMed ID: 8893176
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rhabdomyolysis and anuric kidney failure induced by the treatment with a gemfibrozil-cerivastatin combination].
    Sirvent AE; Cabezuelo JB; Enríquez R; Amorós F; González C; Reyes A
    Nefrologia; 2001; 21(5):497-500. PubMed ID: 11795020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.